1921
Volume 84, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Cutaneous leishmaniasis caused by is rarely encountered outside disease-endemic areas and there have been no clinical trials evaluating its pharmacotherapy. We describe the treatment of cutaneous leishmaniasis caused by using liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.10-0712
2011-05-05
2020-08-04
Loading full text...

Full text loading...

/deliver/fulltext/14761645/84/5/692.html?itemId=/content/journals/10.4269/ajtmh.2011.10-0712&mimeType=html&fmt=ahah

References

  1. Padovese V, Terranova M, Toma L, Barnabas GA, Morrone A, 2009. Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Trans R Soc Trop Med Hyg 103: 707711.[Crossref]
    [Google Scholar]
  2. Bryceson AD, 1970. Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment. Trans R Soc Trop Med Hyg 64: 369379.[Crossref]
    [Google Scholar]
  3. Bray RS, Ashford RW, Bray MA, 1973. The parasite causing cutaneous leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 67: 345348.[Crossref]
    [Google Scholar]
  4. Teklemariam S, Hiwot AG, Frommel D, Miko TL, Ganlov G, Bryceson A, 1994. Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica . Trans R Soc Trop Med Hyg 88: 334339.[Crossref]
    [Google Scholar]
  5. van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB, 1992. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol 51: 133142.[Crossref]
    [Google Scholar]
  6. Davila AM, Momen H, 2000. Internal-transcribed-spacer (ITS) sequences used to explore phylogenetic relationships within Leishmania . Ann Trop Med Parasitol 94: 651654.[Crossref]
    [Google Scholar]
  7. Schönian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, Jaffe CL, 2003. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 47: 349358.[Crossref]
    [Google Scholar]
  8. Ashford RW, Bray MA, Hutchinson MP, Bray RS, 1973. The epidemiology of cutaneous leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 67: 568601.[Crossref]
    [Google Scholar]
  9. Dedet JP, Pratlong F, 2003. Leishmaniasis. Cook GC, Zumla AI, ed. Manson's Tropical Diseases. Philadelphia, PA: Elsevier Saunders, 13391364.
    [Google Scholar]
  10. World Health Organization, 2010. Essential Leishmaniasis Maps. Geographical Distribution of Old World Cutaneous Leishmaniasis Due to L. tropica and Related Species and L. aethiopica. Geneva: World Health Organization.
    [Google Scholar]
  11. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO, 2004. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38: 12611265.[Crossref]
    [Google Scholar]
  12. Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV, 2009. Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerg Infect Dis 15: 956959.[Crossref]
    [Google Scholar]
  13. Negera E, Gadisa E, Yamuah L, Engers H, Hussein J, Kuru T, Hailu A, Gedamu L, Aseffa A, 2008. Outbreak of cutaneous leishmaniasis in Silti Woreda, Ethiopia: risk factor assessment and causative agent identification. Trans R Soc Trop Med Hyg 102: 883890.[Crossref]
    [Google Scholar]
  14. Balzer RJ, Destombes P, Schaller KF, Serie C, 1960. Leishmaniose cutanée pseudolépromateuse en Éthiopie. Bull Soc Pathol Exot 53: 293298.
    [Google Scholar]
  15. Schönian G, Akuffo H, Lewin S, Maasho K, Nylen S, Pratlong F, Eisenberger CL, Schnur LF, Presber W, 2000. Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis. Mol Biochem Parasitol 106: 239248.[Crossref]
    [Google Scholar]
  16. Blum JA, Hatz CF, 2009. Treatment of cutaneous leishmaniasis in travelers 2009. J Travel Med 16: 123131.[Crossref]
    [Google Scholar]
  17. Schwartz E, Hatz C, Blum J, 2006. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 6: 342349.[Crossref]
    [Google Scholar]
  18. Escobar P, Matu S, Marques C, Croft SL, 2002. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop 81: 151157.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.10-0712
Loading
/content/journals/10.4269/ajtmh.2011.10-0712
Loading

Data & Media loading...

  • Received : 20 Dec 2010
  • Accepted : 25 Jan 2011
  • Published online : 05 May 2011
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error